Additional lung-protective perfusion techniques during cardiopulmonary bypass

Annals of Thoracic and Cardiovascular Surgery

Volumn 16, Issue 3, 2010, Pages 150-155

  Suzuki, Takaaki ^a  

^a SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPULMONARY BYPASS; HUMAN; IMMUNOLOGY; LUNG; LUNG DISEASE; REPERFUSION INJURY; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASCULARIZATION;

CARDIOPULMONARY BYPASS; HUMANS; LUNG; LUNG DISEASES; REPERFUSION INJURY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 77955136926     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Ascione R, Loys CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 2000; 69: 1198-204.
2. Wan S, Izzat MB, Lee TW, Wan IYP, Tang NLS, Yim APC. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury. Ann Thorac Surg 1999; 68: 52-7.
3. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57.
4. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 108: 636-41.
5. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105: 234-41.
6. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-34.
7. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 1989; 83: 2008-17.
8. Gillinov AM, Redmond JM, Zehr KJ, Wilson IC, Curtis WE, Bator JM, Burch RM, Reitz BA, Baumgartner WA, Herskowitz A, Cameron DE. Inhibition of neutrophil adhesion during cardiopulmonary bypass. Ann Thorac Surg 1994; 57: 126-33.
9. Howard RJ, Crain C, Franzini DA, Hood CI, Hugli TE. Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation. Arch Surg 1988; 123: 1496-1501.
10. Martin WJ II. Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. Am Rev Respir Dis 1984; 130: 209-13.
11. Harlan JM. Leukocyte-endothelial interactions. Blood 1985; 65: 513-25.
12. Schlensak C, Doenst T, Preusser S, Wunderlich M, Kleinschmidt M, Beyersdorf F. Cardiopulmonary bypass reduction of bronchial blood flow: a potential mechanism for lung injury in a neonatal pig model. J Thorac Cardiovasc Surg 2002; 123: 1199-205.
13. Horgan MJ, Wright SD, Malik AB. Antibody against leukocyte integrin (CD18) prevents reperfusion-induced lung vascular injury. Am J Physiol 1990; 259: L315-9.
14. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass-Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497-503.
15. Royston D, Fleming JS, Desai JB, Westaby S, Taylor KM. Increased production of peroxidation products associated with cardiac operations-Evidence for free radical generation. J Thorac Cardiovasc Surg 1986; 91: 759-66.
16. Hammerschmidt DE, Stroncek DF, Bowers TK, Lammi-Keefe CJ, Kurth DM, et al. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 81: 370-7.
17. Gu YJ, Wang YS, Chiang BY, Gao XD, Ye CX, Wildevuur CRH. Membrane oxygenator prevents lung reperfusion injury in canine cardiopulmonary bypass. Ann Thorac Surg 1991; 51: 573-8.
18. Friedman M, Sellke FW, Wang SY, Weintraub RM, Johnson RG. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation 1994; 90: II-262-8.
19. Chai PJ, Williamson JA, Lodge AJ, Daggett CW, Scarborough JE, et al. Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass. Ann Thorac Surg 1999; 67: 731-5.
20. Kuratani T, Matsuda H, Sawa Y, Kaneko M, Nakano S, et al. Experimental study in a rabbit model of ischemiareperfusion lung injury during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992; 103: 564-8.
21. Drew CE, Anderson IM. Profound hypothermia in cardiac surgery. Report of three cases. Lancet 1959; 1: 748-50.
22. Glenvile B, Ross D. Coronary artery surgery with patient's lungs as oxygenator. Lancet 1986; 2: 1005-6.
23. Mendler N, Heimisch W, Schad H. Pulmonary function after biventricular bypass for autologous lung oxygenation. Eur J Cardiothorac Surg 2000; 17: 325-30.
24. Richter JA, Meisner H, Tassani P, Barankay A, Dietrich W, Braun SL. Drew-Anderson technique attenuates systemic Inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting. Ann Thorac Surg 1999; 69: 77-83.
25. Serraf A, Robotin M, Bonnet N, Détruit H, Baudet B, Mazmanian MG, Hervé P, Planché C. Alteration of the neonatal pulmonary physiology after total cardiopulmonary bypass. J Thorac Cardiovasc Surg 1997; 114: 1061-9.
26. Chai PJ, Williamson JA, Lodge AJ, Daggett CW, Scarborough JE, et al. Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass. Ann Thorac Surg 1999; 67: 731-5.
27. Jaggers JJ, Forbess JM, Shah AS, Meliones JN, Kirshbom PM, et al. Extracorporeal membrane oxygenation for infant postcardiotomy support: Significance of shunt Management. Ann Thorac Surg 2000; 69: 1476-83.
28. Suzuki T, Fukuda T, Ito T, Inoue Y. Cho Y, et al. Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants. Ann Thorac Surg 2000; 69: 602-6.
29. Suzuki T, Ito T, Kashima I, Teruya K, Fukuda T. Continuous perfusion of pulmonary arteries during total cardiopulmonary bypass favorably affects levels of circulating adhesion molecules and lung perfusion. J Thorac Cardiovasc Surg 2001; 122: 242-8.
30. Siepe M, Goebel U, Mecklenburg A, Doenst T, Benk C, et al. Pulsatile pulmonary perfusion during cardiopulmonary bypass reduces the pulmonary inflammatory response. Ann Thorac Surg 2008; 86: 115-22.
31. Gabriel EA, Locali RF, Matsuoka PK, Almeida LS, Silva IG, et al. Lung perfusion during cardiac surgery with cardiopulmonary bypass: is it necessary? Interact CardioVasc Thorac Surg 2008; 7: 1089-95.
32. Wei B, Liu Y, Wang Q, Yu Cuntao, Long Cun Chang Y, et al. Lung perfusion with protective solution relieves lung injury in corrections o Tetralogy of Fallot. Ann Thorac Surg 2004; 77: 918-24.
33. Liu Y, Wang Q, Zhu X, Liu D, Pan S, et al. Pulmonary artery perfusion with protective solution reduces lung injury after cardiopulmonary bypass. Ann Thorac Surg 2000; 69: 1402-7.
34. Fan X, Liu Y, Wang Q, Yu C, Wei B, et al. Lung perfusion with clarithromycin ameliorates lung function after cardiopulmonary bypass. Ann Thorac Surg 2006; 81: 896-901.
35. Sievers H, Freund-Kaas C, Eleftheriadis S, Fischer T, Kuppe H, et al. Lung protection during total cardiopulmonary bypass by isolated perfusion: Preliminary results of a novel perfusion strategy. Ann Thorac Surg 2002; 74: 1167-72.
36. Goebel U, Siepe M, Mecklenburg A, Doenst T, Beyersdorf F, et al. Reduced pulmonary inflammatory response during cardiopulmonary bypass: effects of combined pulmonary perfusion and carbon monoxide inhalation. Eur Cardiothorac Surg 2008; 34: 1165-1172.
37. Badellino MM, Morganroth ML, Grum CM, Lynch MJ, Bolling SF, et al. Hypothermia or continuous ventilation decreases ischemia-reperfusion injury in an ex vivo rat lung model. Surgery 1989; 105: 752-60.